Literature DB >> 26622328

Immunological effect induced by mesenchymal stem cells in a rat liver transplantation model.

Zhenqiang Sun1, Tao Li2, Hao Wen3, Haijiang Wang4, Weizheng Ji5, Yan Ma6.   

Abstract

The aim of the present study was to investigate the immunological effect induced by bone marrow mesenchymal stem cells (MSCs) in rats that had undergone an orthotopic liver transplantation (OLT). MSCs were isolated and cultured from the bone marrow tissue of Lewis rats. In total, 42 rat OLT models were established and equally distributed into three groups. Group A received an OLT only, group B were also intramuscularly injected with tacrolimus (FK506), while group C were not only administered FK506, but also received MSCs. On day 7 post-surgery, the blood levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and total bilirubin (TBIL) were measured. In addition, pathological changes were observed in the liver, levels of immune cytokines, including transforming growth factor (TGF)-α1, interleukin (IL)-10 and IL-12, were determined using immunohistochemistry, MSC homing was assessed and the survival times of the patients were recorded. Liver function, as assessed by the levels of ALT, AST and TBIL, was shown to improve in group C when compared with groups B and A (both P<0.01). In addition, survival analysis revealed that the survival times in groups B (median, 44 days) and C (median, 63 days) were significantly longer compared with group A (median, 11 days; both P<0.01). The survival rate of group C was also higher compared with group B (P<0.01). Pathological examination demonstrated strong acute rejection in group A, a mild acute rejection in group B and the mildest reaction in group C. In addition, immunohistochemistry revealed that TGF-α1 and IL-10 expression was stronger in groups C and B, with group C exhibiting more significant expression than group B. By contrast, expression levels of IL-12 in groups A, B and C were positive, weak-positive and negative, respectively. Therefore, postoperative immunosuppression induced by MSCs is important for the alleviation of immune rejection from recipient-to-graft, and may induce immune tolerance in rat OLT models.

Entities:  

Keywords:  animal model; immune effect; mesenchymal stem cells; orthotopic liver transplantation

Year:  2015        PMID: 26622328      PMCID: PMC4509065          DOI: 10.3892/etm.2015.2551

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  41 in total

1.  Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.

Authors:  Ida Rasmusson; Olle Ringdén; Berit Sundberg; Katarina Le Blanc
Journal:  Transplantation       Date:  2003-10-27       Impact factor: 4.939

2.  Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo.

Authors:  Amelia Bartholomew; Cord Sturgeon; Mandy Siatskas; Karen Ferrer; Kevin McIntosh; Sheila Patil; Wayne Hardy; Steve Devine; David Ucker; Robert Deans; Annemarie Moseley; Ronald Hoffman
Journal:  Exp Hematol       Date:  2002-01       Impact factor: 3.084

3.  Mesenchymal stem cells administered after liver transplantation prevent acute graft-versus-host disease in rats.

Authors:  Xuefeng Xia; Wei Chen; Tao Ma; Guodong Xu; Hao Liu; Chao Liang; Xueli Bai; Yun Zhang; Yong He; Tingbo Liang
Journal:  Liver Transpl       Date:  2012-06       Impact factor: 5.799

4.  Human mesenchymal stem cells modulate allogeneic immune cell responses.

Authors:  Sudeepta Aggarwal; Mark F Pittenger
Journal:  Blood       Date:  2004-10-19       Impact factor: 22.113

5.  Biopsy-directed immunosuppression following hepatic transplantation in man.

Authors:  J W Williams; T G Peters; S R Vera; L G Britt; S J van Voorst; R C Haggitt
Journal:  Transplantation       Date:  1985-06       Impact factor: 4.939

6.  Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation.

Authors:  Roland Meisel; Andree Zibert; Maurice Laryea; Ulrich Göbel; Walter Däubener; Dagmar Dilloo
Journal:  Blood       Date:  2004-03-04       Impact factor: 22.113

7.  [Immunocharacteristics of bone marrow mesenchymal stem cell].

Authors:  Zai-Fa Hong; Xiao-Jin Huang; Zhen-Yu Yin
Journal:  Zhonghua Gan Zang Bing Za Zhi       Date:  2009-01

Review 8.  Liver immunology.

Authors:  Dimitrios P Bogdanos; Bin Gao; M Eric Gershwin
Journal:  Compr Physiol       Date:  2013-04       Impact factor: 9.090

9.  Pulmonary complications and mortality after liver transplant.

Authors:  Serife Savas Bozbas; Fusun Oner Eyuboglu; Figen Ozturk Ergur; Nevra Gullu Arslan; Sinasi Sevmis; Hamdi Karakayali; Mehmet Haberal
Journal:  Exp Clin Transplant       Date:  2008-12       Impact factor: 0.945

10.  Mesenchymal stem cells genetically modified by lentivirus-mediated interleukin-12 inhibit malignant ascites in mice.

Authors:  Jiming Han; Jumei Zhao; Jianrong Xu; Yanjun Wen
Journal:  Exp Ther Med       Date:  2014-08-19       Impact factor: 2.447

View more
  4 in total

1.  Effect of the Combination of Everolimus and Mesenchymal Stromal Cells on Regulatory T Cells Levels and in a Liver Transplant Rejection Model in Rats.

Authors:  Morgan Vandermeulen; Pauline Erpicum; Noella Bletard; Laurence Poma; François Jouret; Olivier Detry
Journal:  Front Immunol       Date:  2022-06-10       Impact factor: 8.786

2.  Research Status of Mesenchymal Stem Cells in Liver Transplantation.

Authors:  Yu You; Di-Guang Wen; Jian-Ping Gong; Zuo-Jin Liu
Journal:  Cell Transplant       Date:  2019-09-12       Impact factor: 4.064

3.  Regulatory effect of rat bone marrow mesenchymal stem cells on Treg/Th17 immune balance in vitro.

Authors:  Kai Wang; Yan-Jun Shi; Zhuo-Lun Song; Bin Wu; Chun-Lei Zhou; Wei Liu; Wei Gao
Journal:  Mol Med Rep       Date:  2020-03-11       Impact factor: 2.952

Review 4.  The immunoregulation of mesenchymal stem cells plays a critical role in improving the prognosis of liver transplantation.

Authors:  Chenxia Hu; Lanjuan Li
Journal:  J Transl Med       Date:  2019-12-10       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.